Timothy Ko, Entheon Biomedical

Psychedelic Spotlight Podcast - En podcast av Psychedelic Spotlight

CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions.